维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

11篇 您的检索式：作者名="Shildkrot"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy显示文摘	Huynh N Shildkrot Y Lobo AM	2012	J Ophthalmic Inflamm Infect2012，2，：	1
	2	Conjunctival melanoma: pitfalls and dilemmas in management 显示文摘	Shildkrot Y Wilson MW	2010	Curr Opin Ophthalmol2010，21，5：	1
	3	Update on posterior uveal melanoma: treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease 显示文摘	Shildkrot Y Wilson MW	2009	Curr Opin Ophthalmol2009，20，6：	1
	4	Cortical activa- tion during word processing in late bilinguals: similarities and differences as revealed by functional magnetic resonance imaging 显示文摘	Marian V Shildkrot Y Blumenfeld H K etc	2007	Journal of Clinical and Experimental Neuropsy- chology2007，，29：	1
	5	Intravitreal triamcinolone for cancer-associated retinopathy refractory to systemic therapy 显示文摘	Huynh N Shildkrot Y Lobo AM	2012	J Ophthalmic Inflamm Infect2012，2，3：	1
	6	The Effect of Cancer Therapies on Pediatric Anophthalmic Sockets显示文摘	Yevgeniy Shildkrot Maria Kirzhner Barrett G. Haik Ibrahim Qaddoumi Carlos Rodriguez-Galindo Matthew W. Wilson	2011	Ophthalmology2011，，：	1
	7	Pediatric Anophthalmic Sockets and Orbital Implants:Outcomes with Polymer-Coated Implants显示文摘	Kirzhner M Shildkrot Y Haik BG		0，，：	1
	8	Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mito- mycin C: complications and recurrences 显示文摘	Ditta LC Shildkrot Y Wilson MW	2011	Ophthalmology2011，118，9：	1
	9	Update on posterior uveal melanoma:treatment of the eye and emerging strategies in the prognosis and treatment of metastatic disease显示文摘	SHILDKROT Y WlLSON M W		0，，06：	1
	10	Cancer-associated retinopa- thy:update on pathogenesis and therapy显示文摘	Shildkrot Y Sobrin L Gragoudas ES	2011	Semin Ophtha\|mol2011，26，45：	1
	11	Prophylaxis with intraocular pressure lowering medication and glaucomatous progression in patients receiving intravitreal anti-VEGF therapy显示文摘AIM: To investigate whether pretreatment with pressurelowering medication prior to anti-vascular endothelial factor(VEGF) injections had an effect on glaucomatous progression in patients with preexisting glaucoma or ocular hypertension(OHT).METHODS: A total of 66 eyes from 54 patients with a preexisting diagnosis of glaucoma or OHT, treated with six or more anti-VEGF injections were selected for chart review. Primary outcome measures were rate of visual field loss in d B/year, rate of change in retinal nerve fiber layer(RNFL) thickness in microns/year, and need for additional glaucoma intervention.RESULTS: The number of eyes requiring additional glaucoma medication was 5 of 20(25.0%) and 14 of 46(30.4%) for the pretreated and non-pretreated groups, respectively. The number of eyes requiring glaucoma laser or surgery was 4 of 20(20.0%) and 13 of 46(28.3%) for the pretreated and non-pretreated groups, respectively. Estimated mean rate of pattern standard deviation decline was not significant in either group(P>0.073), with no difference between groups(P=0.332). Although both groups showed significant RNFL change from baseline(P<0.011), no difference was detected between groups(P=0.467).CONCLUSION: Pretreatment has no detectable effect on structural or functional glaucomatous progression. Patients receiving repeated injections may be at risk for glaucomatous complications requiring invasive intervention.	Jeanette Du James T Patrie Xiao-Yu Cai Bruce E Prum Yevgeniy Shildkrot	2022	International Journal of Ophthalmology(English edition)2022，15，10：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费